The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months. Read More Post navigation Radio station in Poland fired its journalists and replaced them with AI ‘presenters’ Pinterest hit with privacy complaint for unlawfully tracking users
